BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17272320)

  • 21. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
    Liang JT; Huang KC; Lai HS; Lee PH; Sun CT
    Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of mediastinoscopy to diagnosis of mediastinal diseases and staging of lung cancer].
    Chen C; Lin PQ; Lin RB; Kang MQ; Zheng W; Chen DZ
    Ai Zheng; 2007 Jun; 26(6):657-60. PubMed ID: 17562276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
    Watanabe A; Mishina T; Ohori S; Koyanagi T; Nakashima S; Mawatari T; Kurimoto Y; Higami T
    Eur J Cardiothorac Surg; 2008 May; 33(5):812-8. PubMed ID: 18342533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns.
    Wu N; Lv C; Yan S; Duan H; Zheng Q; Wang J; Xiong H; Yang Y
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):240-3. PubMed ID: 18077504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.
    Allen MS; Darling GE; Pechet TT; Mitchell JD; Herndon JE; Landreneau RJ; Inculet RI; Jones DR; Meyers BF; Harpole DH; Putnam JB; Rusch VW;
    Ann Thorac Surg; 2006 Mar; 81(3):1013-9; discussion 1019-20. PubMed ID: 16488712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological investigation of pulmonary pleomorphic carcinoma.
    Yamamoto S; Hamatake D; Ueno T; Higuchi T; Hiratsuka M; Shiraishi T; Iwasaki A; Shirakusa T
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):873-6. PubMed ID: 17942316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lung cancer with a sarcoid-like reaction in the primary tumor].
    Aoki K; Yoshimura K; Hoashi S; Ushio T; Tai H; Itsubo K; Takagi K; Okano H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):466-70. PubMed ID: 9212676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.
    Granetzny A; Boseila A; Wagner W; Krukemeyer G; Vogt U; Hecker E; Koch OM; Klinke F
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):212-6. PubMed ID: 16829087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer.
    Nomori H; Ikeda K; Mori T; Kobayashi H; Iwatani K; Kawanaka K; Shiraishi S; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):780-5. PubMed ID: 17320584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study on perioperative risks and functional results in bronchial and bronchovascular sleeve resections.
    Schirren J; Bölükbas S; Bergmann T; Fisseler-Eckhoff A; Trainer S; Beqiri S
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):35-41. PubMed ID: 19169995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial injection of (32)P-chromic phosphate during lung cancer resection to treat occult lymphatic metastasis.
    Gao W; Liu L; Liu ZY; Li XD; Li C
    Nucl Med Commun; 2009 Jun; 30(6):420-6. PubMed ID: 19398935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.